DNA plasmid manufacturer’s new Texas site has ‘greatly expanded’ capabilities 22-Aug-2022 By Jane Byrne VGXI, a contract developer and manufacturer (CDMO), says its new headquarters and manufacturing facility in Texas is slated to open in the fall.
Lawsuit accuses CDMO of ‘blocking’ COVID-19 vaccine 08-Jun-2020 By Ben Hargreaves Inovio launches a lawsuit against VGXI, claiming that the CDMO has breached its manufacturing contract for vaccine candidate.